Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 89701-89750 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05325073
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
PHASE4
Active, not recruiting
9 participants
Started: Feb 18, 2022 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT05285826
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)
PHASE3
Active, not recruiting
8,100 participants
Started: Feb 18, 2022 · Completed: May 25, 2029
1 condition
1 sponsor
34 locations
NCT04137757
fMRI in Postural Tachycardia Syndrome
NA
Active, not recruiting
21 participants
Started: Feb 18, 2022 · Completed: Dec 1, 2026
1 condition
2 sponsors
1 location
NCT04851613
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
PHASE3
Recruiting
256 participants
Started: Feb 18, 2022 · Completed: Dec 30, 2026
1 condition
1 sponsor
55 locations
NCT05211895
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
PHASE3
Recruiting
860 participants
Started: Feb 18, 2022 · Completed: Sep 12, 2030
1 condition
2 sponsors
260 locations
NCT05269589
Home-based Heat Therapy for Type 2 Diabetes
NA
Recruiting
44 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05329727
The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF
N/A
Recruiting
1,000,000 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05426187
Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Received Placental Malaria Vaccine
N/A
Active, not recruiting
90 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT05237908
Clinical Outcome and Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages
N/A
Active, not recruiting
78 participants
Started: Feb 18, 2022 · Completed: Aug 31, 2028
3 conditions
1 sponsor
1 location
NCT04985643
A Study of Real Life Treatment for Multiple Myeloma (MM)
N/A
Active, not recruiting
357 participants
Started: Feb 18, 2022 · Completed: Jun 20, 2026
1 condition
1 sponsor
24 locations
NCT04957095
Motor Network Physiology
NA
Recruiting
120 participants
Started: Feb 18, 2022 · Completed: Dec 1, 2028
2 conditions
3 sponsors
1 location
NCT05027906
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
PHASE1/PHASE2
Recruiting
48 participants
Started: Feb 18, 2022 · Completed: Jan 31, 2027
1 condition
1 sponsor
9 locations
NCT05450822
Precision Medicine in the Treatment of Epilepsy
N/A
Recruiting
550 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2031
1 condition
1 sponsor
1 location
NCT05203224
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
PHASE2
Recruiting
300 participants
Started: Feb 18, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT05300438
Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.
PHASE1
Active, not recruiting
74 participants
Started: Feb 18, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05141877
Influences of Propofol and Sevoflurane Anesthesia in Brain Tumor
PHASE4
Recruiting
706 participants
Started: Feb 18, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05145400
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
PHASE2
Recruiting
50 participants
Started: Feb 18, 2022 · Completed: Mar 1, 2031
2 conditions
2 sponsors
5 locations
NCT05168930
Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
PHASE2
Recruiting
45 participants
Started: Feb 18, 2022 · Completed: Oct 28, 2028
2 conditions
2 sponsors
4 locations
NCT04971720
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis
PHASE2/PHASE3
Recruiting
160 participants
Started: Feb 18, 2022 · Completed: Jan 1, 2027
6 conditions
2 sponsors
1 location
NCT05112315
Clinical Impact of the IBox As an Early Intervention TooL
NA
Active, not recruiting
507 participants
Started: Feb 18, 2022 · Completed: Feb 28, 2025
7 conditions
1 sponsor
16 locations
NCT06102070
Genetic Susceptibility to Severe Infections
N/A
Recruiting
2,000 participants
Started: Feb 18, 2022 · Completed: Oct 18, 2038
1 condition
1 sponsor
1 location
NCT05138393
Scoliosis-specific Exercises for Mild Idiopathic Scoliosis
NA
Recruiting
90 participants
Started: Feb 18, 2022 · Completed: Nov 30, 2037
1 condition
2 sponsors
2 locations
NCT05150652
Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
PHASE2
Recruiting
70 participants
Started: Feb 18, 2022 · Completed: Oct 31, 2036
4 conditions
1 sponsor
1 location
NCT05247138
Measurement of the Clinical and Radiological Performance Impact of the Root Canal Treatment With BioRootTM RCS.
N/A
Recruiting
142 participants
Started: Feb 18, 2022 · Completed: Jul 1, 2029
1 condition
3 sponsors
11 locations
NCT05240066
Birth Control to Improve Birth Spacing
N/A
Active, not recruiting
1,341 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2025
4 conditions
4 sponsors
2 locations
NCT05190705
Loncastuximab Tesirine in WM
PHASE2
Recruiting
36 participants
Started: Feb 17, 2022 · Completed: Aug 1, 2028
1 condition
2 sponsors
4 locations
NCT05299138
Restoring Empowerment and Choosing Hope (REACH)
NA
Recruiting
900 participants
Started: Feb 17, 2022 · Completed: Jun 1, 2025
2 conditions
1 sponsor
1 location
NCT04975269
Acetazolamide Trial in Normal Pressure Hydrocephalus
PHASE2
Active, not recruiting
50 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05291260
RCT on Nonoperative Versus Operative Treatment for Acute Complete tearS of the Ulnar Collateral ligAment of the Thumb
NA
Active, not recruiting
126 participants
Started: Feb 17, 2022 · Completed: Jul 31, 2026
2 conditions
2 sponsors
1 location
NCT05128825
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE2
Recruiting
170 participants
Started: Feb 17, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
70 locations
NCT05017025
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer
PHASE1/PHASE2
Active, not recruiting
32 participants
Started: Feb 17, 2022 · Completed: Jun 30, 2026
9 conditions
2 sponsors
1 location
NCT05245682
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
EARLY_PHASE1
Active, not recruiting
10 participants
Started: Feb 17, 2022 · Completed: Oct 21, 2025
6 conditions
3 sponsors
1 location
NCT05194995
JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation
PHASE1/PHASE2
Active, not recruiting
48 participants
Started: Feb 17, 2022 · Completed: Jan 31, 2026
3 conditions
1 sponsor
17 locations
NCT05469373
ESIS in Pediatric DRE
N/A
Recruiting
86 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
NCT05492175
Proximal- Versus Distal-Prioritized Robotic Practice Plus Kinetic Exergaming in Stroke Rehabilitation
NA
Recruiting
72 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
4 locations
NCT05381441
Safety Action Feedback and Engagement (SAFE) Loop
NA
Enrolling by invitation
5,163 participants
Started: Feb 17, 2022 · Completed: Jul 31, 2025
2 conditions
2 sponsors
1 location
NCT05212012
D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer
PHASE1/PHASE2
Active, not recruiting
11 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT05992610
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NA
Recruiting
40 participants
Started: Feb 17, 2022 · Completed: Mar 31, 2026
4 conditions
2 sponsors
1 location
NCT05416983
Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer
N/A
Active, not recruiting
37 participants
Started: Feb 17, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT04270838
A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG
PHASE1/PHASE2
Active, not recruiting
174 participants
Started: Feb 17, 2022 · Completed: Sep 30, 2028
1 condition
2 sponsors
1 location
NCT04725643
Keep Contraceptive Arm Long Acting-iMplant (CALM) and Carry On
N/A
Active, not recruiting
55 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2024
3 conditions
2 sponsors
1 location
NCT04772963
Genetics of Central Nervous System Arteriovenous Malformations (GENE-MAV)
N/A
Recruiting
300 participants
Started: Feb 17, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT04966507
Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention
PHASE2
Active, not recruiting
100 participants
Started: Feb 17, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05230537
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
PHASE2
Active, not recruiting
170 participants
Started: Feb 17, 2022 · Completed: Oct 2, 2026
1 condition
1 sponsor
28 locations
NCT04404400
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency
PHASE3
Recruiting
1,092 participants
Started: Feb 17, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT05290038
ARON-2 Study-Multicentric International Retrospective Study
N/A
Recruiting
367 participants
Started: Feb 17, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT05069922
Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation
NA
Recruiting
100 participants
Started: Feb 17, 2022 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT04732091
Therapeutic Use of Contrast Ultrasound in Acute Coronary Artery Disease
N/A
Recruiting
540 participants
Started: Feb 17, 2022 · Completed: Feb 1, 2026
2 conditions
2 sponsors
2 locations
NCT04914611
Real World Assessment of People Living With Chronic Hepatitis B in Australia
N/A
Recruiting
10,000 participants
Started: Feb 17, 2022 · Completed: Jul 1, 2027
1 condition
1 sponsor
19 locations
NCT04917809
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
PHASE2
Active, not recruiting
20 participants
Started: Feb 17, 2022 · Completed: Aug 31, 2026
3 conditions
1 sponsor
7 locations
Previous
1
More pages
1792
1793
1794
1795
1796
1797
1798
More pages
2369
Next